Paul Edick

Mr. Paul R.
Edick was previously employed as a Chairman & Chief Executive Officer by Xeris Biopharma Holdings, Inc., a Chairman by Milestone Pharmaceuticals, Inc., a Chairman & Chief Executive Officer by Xeris Pharmaceuticals, Inc., an Independent Director by Sucampo Pharmaceuticals LLC, a Chairman by Iterum Therapeutics Plc, an Independent Director by PDL BioPharma, Inc., an Independent Director by Neos Therapeutics, Inc., an Independent Non-Executive Director by Circassia Group Plc, an Independent Non-Executive Director by NIOX Healthcare Ltd., an Independent Director by NewLink Genetics Corp., a President, Chief Executive Officer & Director by Durata Therapeutics, Inc., a Chairman by LifeCycle Pharma A/S, a Chief Executive Officer by GANIC Pharmaceuticals, Inc., a Chairman by Life Cycle Pharma A/S, a Managing Partner by 3G Advisors LLC, a Chief Executive Officer by MedPointe Healthcare, Inc., a President & Chief Executive Officer by MedPointe, Inc., a VP, President-Asia Pacific & Latin America by Pharmacia Corp., a President-Asia Pacific, Canada & Latin America by G.D.
Searle & Co., Inc., a Principal by Baxter Healthcare Corp., a Sales Representative by Procter & Gamble Co., a President by MedPointe Capital Partners LLC, a President-Asia Pacific, Canada & Latin America by Searle Pharmaceuticals Pvt Ltd., and a President by Vicuron Pharmaceuticals LLC.
He also served on the board at Vistagen Therapeutics, Inc., Amerita, Inc. and Informed Medical Communications, Inc. He received his undergraduate degree from Hamilton College (New York).